The Effect of Dabigatran Plasma Concentrations and Patient Characteristics on the Frequency of Ischemic Stroke and Major Bleeding in Atrial Fibrillation PatientsPaul Reilly, Lars Wallentin, Stuart J. Connolly et al.|Journal of the American College of Cardiology|2013Cited by 826
60 SILEN-C1: SUSTAINED VIROLOGIC RESPONSE (SVR) AND SAFETY OF BI201335 COMBINED WITH PEGINTERFERON ALFA-2A AND RIBAVIRIN (P/R) IN TREATMENT-NAIVE PATIENTS WITH CHRONIC GENOTYPE 1 HCV INFECTIONMark Sulkowski, Gerhard Steinmann, Jacob Lalezari et al.|Journal of Hepatology|2011Cited by 39